Curexo Inc.

Total Valuation

Curexo Inc. carries a market capitalization of 470.07B, placing it among publicly traded companies globally. Its enterprise value stands at 581.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Curexo Inc. trades at a trailing price-to-earnings ratio of 282.20. The price-to-sales ratio is 8.50, and the price-to-book ratio stands at -4.82.

Enterprise Valuation

On an enterprise value basis, Curexo Inc. trades at an EV/EBITDA multiple of 959.94 and an EV/FCF ratio of 294.25. The EV/Sales ratio of 8.21 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 959.94 provides insight into valuation relative to core operating earnings.

Financial Position

Curexo Inc. maintains a current ratio of 16.73, meaning it holds 16.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.01, indicating moderate leverage, while an interest coverage ratio of 7.77 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Curexo Inc. has paid 31.31M in income taxes, reflecting an effective tax rate of 1.44.

Stock Price Statistics

Curexo Inc.'s stock has gained approximately 15.20645% over the past 52 weeks. The 50-day moving average sits at 14,804.00, while the 200-day moving average is 13,170.15.

Income Statement

Over the trailing twelve months, Curexo Inc. generated 70.92B in revenue and converted that into 2.14B in net income, yielding earnings per share of 51.75. EBITDA reached 606.24M, while operating income came in at 606.24M.

Balance Sheet

Curexo Inc. holds 22.05B in cash and equivalents against 990.83M in total debt, resulting in a net debt position of -16.90B. Total book value stands at -125.12B, with working capital of 84.05B providing operational flexibility.

Cash Flow

Curexo Inc. produced -4.82B in operating cash flow over the past twelve months. After subtracting -2.20B in capital expenditures, free cash flow totaled -7.02B - equivalent to -170.02 per share.

Margins

Curexo Inc. operates with a gross margin of 32.46, reflecting its pricing power and cost economics. The operating margin of 0.85 and net profit margin of 3.01 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Curexo Inc.'s most recent stock split took place on January 11, 2018 with a 20:21 split ratio.

Scores

Curexo Inc. posts an Altman Z-Score of 60.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.